| Project/Area Number |
25462858
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Morphological basic dentistry
|
|---|
| Research Institution | Hiroshima University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
YOSHIKO YUJI 広島大学, 大学院医歯薬保健学研究院, 教授 (20263709)
|
|---|
| Co-Investigator(Renkei-kenkyūsha) |
FUTAMURA MANABU 岐阜大学, 医学部, 准教授 (10415515)
KOZAI KATSUYUKI 広島大学, 大学院医歯薬保健学研究院, 教授 (10178212)
|
|---|
| Project Period (FY) |
2013-04-01 – 2016-03-31
|
| Project Status |
Completed (Fiscal Year 2015)
|
| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
|---|
| Keywords | Klotho / FGF23 / 骨代謝 / リン代謝 / 骨転移 / 細胞・組織 / がん細胞 |
|---|
| Outline of Final Research Achievements |
Soluble Klotho (sKL) was detected in the several cancer cell lines and stimulated ERK signaling in vitro in the combination with FGF23 which is derived from bone. However, sKL-mediated ERK signaling was tissue-specifically regulated because of the presence of the protease(s) by which FGF23 was processed.
Downstream factor of sKL and FGF23, X, was identified by DNA microarray. X inhibited bone matrix mineralization in vivo and in vitro, but did not affect on proliferation and differentiation in both osteoblast and osteoclast cell cultures. X was strongly detected in bone matrix. osteoblasts and osteocytes with immunohistochemistry by anti-X polyclonal antibody.
|
